Please provide your email address to receive an email when new articles are posted on . “Many health care systems are discussing a transition to dry-powder inhalers that have a lower carbon footprint ...
U.S. FDA Approves Alexza's ADASUVE® (loxapine) Inhalation Powder for the Acute Treatment of Agitation Associated with Schizophrenia or Bipolar I Disorder in Adults MOUNTAIN VIEW, Calif., Dec. 21, 2012 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback